profit from every $100 of sales.
$0$100
BIO-key International
$2.58+4.03% today
-71.8% in 1 year
1-year low $1.651-year high $10.30
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2021 to 2024.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What BIO-key International sold, what it kept, and what it did with the cash.
Sales went from $5.11 million in 2021 to $6.93 million in 2024, with -$4.30 million of profit last year.
SalesProfit
BIO-key International vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| BIO-key International | No profit yet | ||
 ASSA Abloy | 29.8× · Fair price | ||
 SECOM | 25.5× · Fair price | ||
 Allegion | 25.1× · Fair price | ||
 Verisure | No profit yet |
AI analysis
An AI analyst reads BIO-key International's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| 5 | 7 | 8 | 7 | |
| 3 | 5 | 1 | 6 | |
| -5 | -8 | -9 | -4 | |
| -5 | -11 | -8 | -4 | |
| -5 | -12 | -9 | -4 | |
| -117.00 | -226.80 | -152.10 | -21.00 | |
| 67.3% | 65.2% | 18.5% | 81.4% | |
| -97.8% | -120.9% | -113.8% | -57.9% | |
| -99.0% | -169.7% | -109.9% | -62.1% |
Balance sheet
| In millions of USD | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 18 | 11 | 5 | 9 |
| Cash | 8 | 3 | 1 | 0 |
| Total debt | 0 | 3 | 0 | 2 |
| Total liabilities | 2 | 6 | 3 | 5 |
| 16 | 5 | 1 | 4 | |
| 0 | 0 | 0 | 0 | |
| -25.1% | -110.2% | -466.5% | -59.1% | |
| -32.4% | -224.6% | -801.3% | -114.0% |
Cash flow
| In millions of USD | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| -9 | -6 | -4 | -3 | |
| 0 | 0 | 0 | 0 | |
| -9 | -6 | -4 | -3 | |
| Dividends paid | – | – | – | – |
| – | 0 | 1 | – | |
| 0 | 0 | 0 | 0 |
Valuation
- –
- –
- –
- 0.3×
- 0.8×
- –
- –
- -55.7%
- -81.9%
- 0.0%
Profitability
- 81.4%
- -57.9%
- -62.1%
- -65.6%
- -54.6%
- -180.9%
- -65.4%
- -42.2%
- -54.8%
- 42.8%
Growth
- +10.7%
- –
- −59.7%
- –
- +98.0%
Financial health
- –
- 0.01
- 0.5%
- -13.4×
- 1.49
- 1.37
- 0.56
How it ranks in Industrials
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 1%of 980
Bottom 1%of 986
Top 32%of 986
Bottom 1%of 988
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 18, 2026 | -0.15 | -0.60 | +75.0% |
| Mar 31, 2026 | -1.90 | -0.70 | −171.4% |
| Nov 14, 2025 | -0.15 | -0.12 | −25.0% |
| Aug 13, 2025 | -0.20 | -0.15 | −33.3% |
| May 15, 2025 | -0.16 | -0.24 | +33.3% |
| Mar 27, 2025 | -0.53 | -0.35 | −51.4% |
| Nov 14, 2024 | -0.39 | -0.39 | +0.0% |
| Aug 14, 2024 | -1.00 | -0.54 | −85.2% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
27No pass
Benjamin Graham
63Pass
Philip Fisher
41No pass
Peter Lynch
49No pass
Joel Greenblatt
2No pass
Charlie Munger
38No pass
Terry Smith
41No pass
Questions about BIO-key International
Is BIO-key International a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the BIO-key International AI analysis
What does BIO-key International do?
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. It is in Security & Protection Services.
Does BIO-key International pay a dividend?
No. BIO-key International does not pay a dividend at the moment.
Is BIO-key International stock halal?
No. BIO-key International does not pass our halal screen: its debt is 34% of its market value, at or above the 33% limit. How we check
How has BIO-key International stock done over the past year?
Down 71.8% over the past twelve months, to $2.58. It traded between $1.65 and $10.30 and is 75.0% below its high.
Who are BIO-key International's competitors?
The largest listed companies in the same industry are ASSA Abloy, SECOM, Allegion and Verisure. The peers table on this page compares their profit, growth and price with BIO-key International's.
Prices: daily closes to Nov 12, 2026. Fundamentals: company reports via invest-like data.